JPRN-UMIN000030167
已完成
未知
A multicenter, randomized, trial to test non-inferiority of microhook ab interno trabeculotomy against Trabectome for an intraocular pressure lowering effect and safety - Trabectome versus Microhook ab interno Trabeculotomy Comparative Study (TramTrac Study)
Kobe University Hospital, Department of Ophthalmology0 个研究点目标入组 47 人2018年2月28日
适应症Glaucoma
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Glaucoma
- 发起方
- Kobe University Hospital, Department of Ophthalmology
- 入组人数
- 47
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
Due to the COVID-19 pandemic, it is practically difficult to enroll new candidates and follow up post surgical participants. Therefore, this study has been to be terminated.
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\) A patient with only one functional eye 2\) Inapplicability to Goldmann applanation tonometry 3\) Presence or a history of uveitis 4\) A patient who received oral, topical, or subTenon injection of corticosteroid within 6 months 5\)Presence or a history of diabetes 6\) A pacemaker recipient 7\) A patient who received cataract surgery on the nominated eye withn 6 months 8\) A history of laser trabeculoplasty or laser iridotomy 9\) Corneal endothelial density less than 1000/mm2 10\) A pregnant or breast\-feeding woman, or a woman who plans to be pregnant 11\) An individual who participated in other studies within 4 months 12\) A patient judged to be ineligible for any reason by a doctor in charge
结局指标
主要结局
未指定
相似试验
已完成
不适用
Palliative Care EducatorAdvance Care PlanningPalliative CareAlzheimer's Disease and Related DementiasDoctor-patient CommunicationVideo Decision AidsNCT04857060Tufts Medical Center11,174
已完成
2 期
Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 PneumoniaCOVID-19NCT04445272Fundacion SEIMC-GESIDA495
已完成
2 期
Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID)Covid-19NCT04357808Maria del Rosario Garcia de Vicuña Pinedo30
撤回
3 期
A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19COVID-19NCT04433013Nanyang Technological University
终止
2 期
The Nitazoxanide Plus Atazanavir for COVID-19 StudyCovid-19NCT04459286Obafemi Awolowo University57